however, under conditions of mitochondrial dysfunction, BCAA metabolic intermediates accumulate, producing toxic effects (113)
Ochsner inspires healthier lives and stronger communities through our mission to serve, heal, lead, educate and innovate
Results showed Cerebrolysin was significantly more effective than placebo for cognitive function at 4 weeks (SMD -0.40, p=0.003), global clinical change at both 4 weeks (OR 3.32, p=0.02) and 6 months (OR 4.98, p=0.015), and combined global benefit (cognitive + clinical) at both timepoints
On April 1, 2026, the FDA approved Foundayo (orforglipron) from Eli Lillythe first oral small-molecule GLP-1 receptor agonist for chronic weight management
After the FDA approved Zepbound for moderate-to-severe OSA in December 2024, most Cigna plans added an OSA coverage pathway